A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm
Clinical trial NCT05048160 · UNKNOWN
Trial details
- NCT number
- NCT05048160
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-27
- Primary completion
- 2024-06-01
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.